Breaking News

Worldwide Clinical Trials Selects BioClinica's OnPoint CTMS

By Kristin Brooks | March 6, 2014

Aims to improve efficiencies in data and work flow with reduced operational expenses

Worldwide Clinical Trials, Inc. has selected BioClinica's OnPoint CTMS (clinical trial management system) to support international studies for all phases of drug development in various therapeutic areas. With the implementation of OnPoint CTMS, Worldwide Clinical anticipates improved efficiencies in data flow and workflow with cost-savings in time, labor, and operational expenses.

OnPoint will provide role-based access to users globally, including clinical research associates, monitors, study managers, operations and site personnel, as well as executives and sponsor users. OnPoint manages a clinical trial from the start and maintains role-based access control from study design through close-out and FDA submission. The CTMS includes tools to plan, start, conduct, and manage studies and complete monitoring and regulatory compliance activities.

"We believe well-integrated technologies enhance clinical development and the decision to replace our existing trial management system with BioClinica's OnPoint reflects this. It also gives us broader functionality along with predictable pricing," said Tom Wardle, chief operating officer, Worldwide Clinical Trials. "After conducting an extensive evaluation of industry-leading CTMS providers, we selected OnPoint for its flexibility, scalability, and superior technical support." BioClinica's Office-smart CTMS utilizes Microsoft SharePoint to foster collaboration and connectivity in multi-site study environments.

BioClinica's Peter Benton, president of eClinical Solutions, said, "With the large amount of data generated across so many trials and individual study activities, it can be hard to control and manage it all. Because OnPoint handles studies of any size and complexity securely and compliantly, we're seeing wide adoption by major players like Worldwide Clinical Trials. Everyone who sees our MVR wants it." BioClinica's innovative Monitor Visit Report (MVR)replaces conventional manual transcription with an electronic visit report that can be securely accessed and updated anytime and anywhere whether online or offline.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important